June 16th 2025
Explore how health equity and policy shape outcomes, revealing disparities in kidney disease, atopic dermatitis, and cancer care for vulnerable populations.
Survey Shows Importance of Discussing, Treating Endocrine Effects of Steroids for DMD
July 12th 2024Results from a national survey of patients with Duchenne muscular dystrophy (DMD) and their families found that patients and families want to be informed early about endocrine complications associated with glucocorticoid treatment.
Read More
CMS Unveils Proposed 2025 Physician Fee Schedule, Maternal Health Standards
July 11th 2024The 2025 Physician Fee Schedule includes a conversion factor reduction, expanded behavioral health services, extended telehealth waivers, new Quality Payment Program pathways, and measures to address suspect billing, alongside a Biden administration initiative introducing federal maternal health standards for hospitals.
Read More
Dr Rachel Dalthorp: Zuranolone, the First Line of Treatment for Postpartum Depression
July 10th 2024Rachel Dalthorp, MD, explains that zuranolone is recommended as the first-line medication, alongside psychotherapy, to effectively manage postpartum depression (PPD) and mitigate long-term impacts.
Watch
Telehealth Can Drive More Meaningful Serious Illness Conversations in MDS, AML
July 10th 2024Researchers collected feedback from 20 clinicians implementing a telehealth serious illness conversation (SIC) with their patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Read More
VEXAS Syndrome Often Misdiagnosed as Pyoderma Gangrenosum
July 3rd 2024In a recently published systematic review, researchers determined that VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome typically presents in men, with atypical morphology and with systemic symptoms.
Read More
Final Readout of FIREFISH Study Showcases Risdiplam’s Pronounced Effects in Spinal Muscular Atrophy
July 3rd 2024The FIREFISH study showed that most children with type I spinal muscular atrophy (SMA) maintained or improved motor functions and feeding abilities over 5 years when treated with risdiplam.
Read More